Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1854, Issue 6, 2015, Pages 624-631

  Poschmann, Gereon ^a   Grzendowski, Michael ^b,d   Stefanski, Anja ^a   Bruns, Eva ^a   Meyer, Helmut Erich ^b,c   Stühler, Kai ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

^d ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cancer Redox process PRDX1 Thiol Chemoresistance Glioma

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; PEROXIREDOXIN; PRDX1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TUMOR PROTEIN;

DNA DAMAGE; DRUG EFFECTS; DRUG RESISTANCE; GENE DELETION; GENETICS; GLIOMA; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PROCEDURES; PROTEOMICS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CELL LINE, TUMOR; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GENE DELETION; GLIOMA; HUMANS; NEOPLASM PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIREDOXINS; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 84939943110     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.11.011     Document Type: Article

References (43)

1. Q.T. Ostrom, H. Gittleman, P. Farah, A. Ondracek, Y. Chen, Y. Wolinsky, N.E. Stroup, C. Kruchko, and J.S. Barnholtz-Sloan CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010 Neuro-Oncology 15 Suppl. 2 2013 ii1 ii56
2. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114 2007 97 109
3. W. Wick, C. Hartmann, C. Engel, M. Stoffels, J. Felsberg, F. Stockhammer, M.C. Sabel, S. Koeppen, R. Ketter, R. Meyermann, M. Rapp, C. Meisner, R.D. Kortmann, T. Pietsch, O.D. Wiestler, U. Ernemann, M. Bamberg, G. Reifenberger, A. von Deimling, and M. Weller NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide J. Clin. Oncol. 27 2009 5874 5880
4. J.G. Cairncross, K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D.R. Macdonald, Y. Ino, D.A. Ramsay, and D.N. Louis Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J. Natl. Cancer Inst. 90 1998 1473 1479
5. M.J. van den Bent, A.F. Carpentier, A.A. Brandes, M. Sanson, M.J. Taphoorn, H.J. Bernsen, M. Frenay, C.C. Tijssen, W. Grisold, L. Sipos, H. Haaxma-Reiche, J.M. Kros, M.C. van Kouwenhoven, C.J. Vecht, A. Allgeier, D. Lacombe, and T. Gorlia Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial J. Clin. Oncol. 24 2006 2715 2722
6. M. Grzendowski, M. Wolter, M.J. Riemenschneider, C.B. Knobbe, U. Schlegel, H.E. Meyer, G. Reifenberger, and K. Stuhler Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q Neuro-Oncology 12 2010 243 256
7. B. Tews, J. Felsberg, C. Hartmann, A. Kunitz, M. Hahn, G. Toedt, K. Neben, L. Hummerich, A. von Deimling, G. Reifenberger, and P. Lichter Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling Int. J. Cancer 119 2006 792 800
8. L.M. Dittmann, A. Danner, J. Gronych, M. Wolter, K. Stuhler, M. Grzendowski, N. Becker, J. Bageritz, V. Goidts, G. Toedt, J. Felsberg, M.C. Sabel, S. Barbus, G. Reifenberger, P. Lichter, and B. Tews Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro Oncogene 31 2012 3409 3418
9. S. Barranco-Medina, J.J. Lazaro, and K.J. Dietz The oligomeric conformation of peroxiredoxins links redox state to function FEBS Lett. 583 2009 1809 1816
10. C.A. Neumann, J. Cao, and Y. Manevich Peroxiredoxin 1 and its role in cell signaling Cell Cycle 8 2009 4072 4078
11. J. Park, S. Lee, S. Lee, and S.W. Kang 2-cys peroxiredoxins: emerging hubs determining redox dependency of Mammalian signaling networks Int. J. Cell Biol. 2014 2014 715867
12. C.A. Neumann, D.S. Krause, C.V. Carman, S. Das, D.P. Dubey, J.L. Abraham, R.T. Bronson, Y. Fujiwara, S.H. Orkin, and R.A. Van Etten Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression Nature 424 2003 561 565
13. Q.K. Sun, J.Y. Zhu, W. Wang, Y. Lv, H.C. Zhou, J.H. Yu, G.L. Xu, J.L. Ma, W. Zhong, and W.D. Jia Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma Med. Oncol. 31 2014 786
14. J.H. Kim, P.N. Bogner, S.H. Baek, N. Ramnath, P. Liang, H.R. Kim, C. Andrews, and Y.M. Park Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target Clin. Cancer Res. 14 2008 2326 2333
15. M.F. Chen, K.D. Lee, C.H. Yeh, W.C. Chen, W.S. Huang, C.C. Chin, P.Y. Lin, and J.Y. Wang Role of peroxiredoxin I in rectal cancer and related to p53 status Int. J. Radiat. Oncol. Biol. Phys. 78 2010 868 878
16. T. Yanagawa, K. Omura, H. Harada, T. Ishii, J. Uwayama, K. Nakaso, S. Iwasa, Y. Koyama, K. Onizawa, H. Yusa, and H. Yoshida Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence Int. J. Oral Maxillofac. Surg. 34 2005 915 920
17. C.X. Liu, H.C. Zhou, Q.Q. Yin, Y.L. Wu, and G.Q. Chen Targeting peroxiredoxins against leukemia Exp. Cell Res. 319 2013 170 176
18. G. Poschmann, B. Sitek, B. Sipos, A. Ulrich, S. Wiese, C. Stephan, B. Warscheid, G. Kloppel, A. Vander Borght, F.C. Ramaekers, H.E. Meyer, and K. Stuhler Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium Mol. Cell. Proteomics 8 2009 1105 1116
19. J. Klose, and U. Kobalz Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome Electrophoresis 16 1995 1034 1059
20. G. Poschmann, B. Sitek, B. Sipos, and K. Stuhler Application of saturation labeling in lung cancer proteomics Methods Mol. Biol. 854 2012 253 267
21. H. Schaefer, D.C. Chamrad, K. Marcus, K.A. Reidegeld, M. Bluggel, and H.E. Meyer Tryptic transpeptidation products observed in proteome analysis by liquid chromatography-tandem mass spectrometry Proteomics 5 2005 846 852
22. D.N. Perkins, D.J. Pappin, D.M. Creasy, and J.S. Cottrell Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 20 1999 3551 3567
23. J.A. Vizcaino, E.W. Deutsch, R. Wang, A. Csordas, F. Reisinger, D. Rios, J.A. Dianes, Z. Sun, T. Farrah, N. Bandeira, P.A. Binz, I. Xenarios, M. Eisenacher, G. Mayer, L. Gatto, A. Campos, R.J. Chalkley, H.J. Kraus, J.P. Albar, S. Martinez-Bartolome, R. Apweiler, G.S. Omenn, L. Martens, A.R. Jones, and H. Hermjakob ProteomeXchange provides globally coordinated proteomics data submission and dissemination Nat. Biotechnol. 32 2014 223 226
24. A. Franceschini, D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic, A. Roth, J. Lin, P. Minguez, P. Bork, C. von Mering, and L.J. Jensen STRING v9.1: protein-protein interaction networks, with increased coverage and integration Nucleic Acids Res. 41 2013 D808 D815
25. G. Poschmann, A. Lendzian, J. Uszkoreit, M. Eisenacher, A.V. Borght, F.C. Ramaekers, H.E. Meyer, and K. Stuhler A combination of two electrophoretical approaches for detailed proteome-based characterization of SCLC subtypes Arch. Physiol. Biochem. 119 2013 114 125
26. J. Guo, M.J. Gaffrey, D. Su, T. Liu, D.G. Camp II, R.D. Smith, and W.J. Qian Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications Nat. Protoc. 9 2014 64 75
27. M.E. Law, K.L. Templeton, G. Kitange, J. Smith, A. Misra, B.G. Feuerstein, and R.B. Jenkins Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines Cancer Genet. Cytogenet. 160 2005 1 14
28. T.R. Hurd, T.A. Prime, M.E. Harbour, K.S. Lilley, and M.P. Murphy Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: implications for mitochondrial redox signaling J. Biol. Chem. 282 2007 22040 22051
29. G. Cairncross, B. Berkey, E. Shaw, R. Jenkins, B. Scheithauer, D. Brachman, J. Buckner, K. Fink, L. Souhami, N. Laperierre, M. Mehta, and W. Curran Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 24 2006 2707 2714
30. L.M. Dittmann, A. Danner, J. Gronych, M. Wolter, K. Stuhler, M. Grzendowski, N. Becker, J. Bageritz, V. Goidts, G. Toedt, J. Felsberg, M.C. Sabel, S. Barbus, G. Reifenberger, P. Lichter, and B. Tews Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro Oncogene 31 29 2012 3409 3418
31. B. Wiestler, R. Claus, S.A. Hartlieb, M.G. Schliesser, E.K. Weiss, T. Hielscher, M. Platten, L.M. Dittmann, C. Meisner, J. Felsberg, C. Happold, M. Simon, G. Nikkhah, K. Papsdorf, J.P. Steinbach, M. Sabel, C. Grimm, D. Weichenhan, B. Tews, G. Reifenberger, D. Capper, W. Muller, C. Plass, M. Weller, W. Wick, and S. Neuro-oncology Working Group of the German Cancer Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective Neuro-Oncology 15 2013 1017 1026
32. H.S. Maker, C. Weiss, and T.S. Brannan The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue Res. Commun. Chem. Pathol. Pharmacol. 40 1983 355 366
33. P. Aguilar-Melero, M.J. Prieto-Alamo, J. Jurado, A. Holmgren, and C. Pueyo Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1 J. Proteome 79 2013 161 171
34. G. Chiappetta, S. Ndiaye, A. Igbaria, C. Kumar, J. Vinh, and M.B. Toledano Chapter 10 - Proteome Screens for Cys Residues Oxidation: The Redoxome C. Enrique, P. Lester, Methods in Enzymology vol. 473 2010 Academic Press 199 216
35. M. Chevallet, E. Wagner, S. Luche, A. van Dorsselaer, E. Leize-Wagner, and T. Rabilloud Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress J. Biol. Chem. 278 2003 37146 37153
36. A. Higa, and E. Chevet Redox signaling loops in the unfolded protein response Cell. Signal. 24 2012 1548 1555
37. K. Niforou, C. Cheimonidou, and I.P. Trougakos Molecular chaperones and proteostasis regulation during redox imbalance Redox Biol. 2 2014 323 332
38. P.C. Wei, Y.H. Hsieh, M.I. Su, X. Jiang, P.H. Hsu, W.T. Lo, J.Y. Weng, Y.M. Jeng, J.M. Wang, P.L. Chen, Y.C. Chang, K.F. Lee, M.D. Tsai, J.Y. Shew, and W.H. Lee Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease Mol. Cell 48 2012 747 759
39. Y.M. Go, D.M. Duong, J. Peng, and D.P. Jones Protein cysteines map to functional networks according to steady-state level of oxidation J. Proteomics Bioinforma. 4 2011 196 209
40. J. Sun, M. Morgan, R.F. Shen, C. Steenbergen, and E. Murphy Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport Circ. Res. 101 2007 1155 1163
41. C. Berndt, G. Poschmann, K. Stuhler, A. Holmgren, and L. Brautigam Zebrafish heart development is regulated via glutaredoxin 2 dependent migration and survival of neural crest cells Redox Biol. 2 2014 673 678
42. P.A. Madureira, and D.M. Waisman Annexin A2: the importance of being redox sensitive Int. J. Mol. Sci. 14 2013 3568 3594
43. S. Kehr, E. Jortzik, C. Delahunty, J.R. Yates III, S. Rahlfs, and K. Becker Protein S-glutathionylation in malaria parasites Antioxid. Redox Signal. 15 2011 2855 2865